Arginine Vasopressin Hormone
Vasopressin is a nanopeptide synthesized by paraventricular and supraoptic nuclei of the hypothalamus and then stored in the posterior pituitary. It is also called arginine vasopressin (AVP) because most mammalian vasopressin molecules contain an arginine at position number 8. Vasopressin’s major function is to maintain osmotic homeostasis by regulating water resorption and it is therefore also called antidiuretic hormone (ADH). The secretion of AVP is mainly stimulated when the serum osmolality exceeds 295 mOsm/kg and is suppressed when the osmolality decreases below 284 mOsm/kg. AVP secretion can also be stimulated by decreased blood pressure, pain, stress, sleep, exercise, and chemical agents such as angiotensin II, opiates, prostaglandin, nicotine, and barbiturates. AVP acts to increases water retention from renal tubules after binding to V2 receptors, thereby increasing translocation of aquaporin-2 water channels from intracellular pool to the apical membrane. Hypofunction and hyperfunction of AVP are known as diabetes insipidus (DI) and syndrome of inappropriate ADH secretion (SIADH), respectively.
DI is characterized by excessive loss of water into the urine leading to decreased urine osmolality and increased serum osmolality. DI secondary to failure of the posterior pituitary to secrete appropriate amounts of AVP is called as hypothalamic, neurogenic or cranial DI. The incidence of neurogenic DI is about 1 in 25,000 with 30% of cases being idiopathic. The remaining cases are secondary to head trauma, neoplastic diseases, autoimmune diseases, ischemic and hypoxic pituitary damage, or following cranial surgery. DI can be caused by the failure of renal tubules to respond to normal or increased concentration of AVP (Nephrogenic DI). Nephrogenic DI may be secondary to various congenital disorders or acquired conditions that lead to tubular injury. Excessive intake of water can also impair the concentrating ability of kidney (Psychogenic polydipsia).
SIADH is due to the inappropriate and sustained secretion of AVP without recognized stimuli even when plasma osmolality is low. It is characterized by hyponatremia (Na<130 mmol/L) and hypoosmolality (<275 mOsm/kg). It may result from ectopic secretion of AVP by malignant cells, acute or chronic CNS disease, pulmonary disorders or the effects of certain drugs. Measurement of AVP aids in the diagnosis of disorders related to deficiency or excessive secretion of AVP. Measurement of AVP can also be done as part of water deprivation test (for DI) or water loading test (for SIADH).
- Differential diagnosis of diabetes insipidus
- As an aid in diagnosis of syndrome of inappropriate antidiuretic hormone secretion (SIADH)
- As an aid in diagnosis of psychogenic water intoxication
Increased in:
- Syndrome of inappropriate ADH secretion (SIADH)
- Nephrogenic diabetes insipidus
- Ectopic secretion of AVP (small cell carcinoma of the lungs)
- Side effect of certain drugs therapies
Decreased in:
- Neurogenic diabetes insipidus
- Psychogenic polydipsia
- ADH resistance
- Renal tubular disease
0.35- 11.94 ng/L A significant amount of AVP is associated with platelets. Therefore, the AVP concentration should be interpreted considering conditions affecting platelet functions.
Radioimmuno assay (RIA), immunoassay, Liquid chromatography, tandem mass spectrometry (LCMS).
Plasma (EDTA). Blood should collect in prechilled EDTA tubes and processed at 4 C within 30 min of collection.
Stability
- Ambient: 1 hour
- Refrigerated: 6 hour
- Frozen: 1 month
Serum or urine osmolality, sodium, Renin.
3-7 days.
- Endocrinol Metab Clin North Am. 2001 Sep;30(3):671-94. [PMID: 11571936]
- Am J Med. 2006 Jul;119(7 Suppl 1):S36-42. [PMID: 16843083]
- Expert Rev Anticancer Ther. 2006 Sep;6 Suppl 9:S63-74. [PMID: 17004859]
- Pediatr Endocrinol Rev. 2006 Dec;4 Suppl 1:60-5. [PMID: 17261971]
- Int J Biochem Cell Biol. 2003 Nov;35(11):1495-9. [PMID: 12824060]
- Endocrinol Metab Clin North Am. 1995 Sep;24(3):549-72. [PMID: 8575409]
- Winter WE, Vance ML. Pituitary Function and Pathophysiology. Textbook of Clinical Chemistry and Molecular Diagnostics. 5th ed. 2012. Page 1803 – 45.
- Guber HA, Farag AF. Evaluation of Endocrine Function. Henry’s Clinical Diagnosis and Management by Laboratory Methods. 22nd ed 2011. Page 364 – 401.
- Robinson AG, Verbalis JG. Posterior Pituitary. Williams Textbook of Endocrinology. 12th ed. 2011. Page 291 – 323.